Fabrice Bruno CHRETIEN,Raphael GAILLARD,Pierre ROCHETEAU
申请号：
US15768001
公开号：
US20180303772A1
申请日:
2016.07.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the field of myocardial infraction (MI). It more specifically relates to an agent stimulating, either directly or indirectly, the 5-hydroxytryptamine 1B receptor, and to a composition comprising said agent, for use in the treatment of a patient having a myocardial infraction (MI). The invention further encompasses therapeutic and screening methods.
